Attached files

file filename
EX-31.1 - EX-31.1 - Synthetic Biologics, Inc.v358947_ex31-1.htm
EX-32.2 - EX-32.2 - Synthetic Biologics, Inc.v358947_ex32-2.htm
EX-31.2 - EX-31.2 - Synthetic Biologics, Inc.v358947_ex31-2.htm
EXCEL - IDEA: XBRL DOCUMENT - Synthetic Biologics, Inc.Financial_Report.xls
10-Q - 10-Q - Synthetic Biologics, Inc.v358947_10q.htm

  

EXHIBIT 32.1

 

CERTIFICATION PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Synthetic Biologics, Inc. (the “Registrant”) hereby certifies, to such officer’s knowledge, that:

 

(1) the accompanying Quarterly Report on Form 10-Q of the Registrant for the quarter ended September 30, 2013 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

Date: November 14, 2013  
     
  By: /s/ Jeffrey Riley
    Name: Jeffrey Riley
    Title: President and Chief Executive Officer
    (Principal Executive Officer)